Introduction: Studies on urinary tract infections (UTIs) in West Africa from 1990 to 2012 have showed moderate to high antimicrobial resistance
Introduction
Urinary tract infection (UTI) is one of the commonly reported microbial infections at healthcare settings. UTI can affect all ages and both sexes, although prevalence is known to be higher amongst females [1] . Reports suggest that there could be spontaneous resolution of UTI (rates between 50 -70%) without any pharmacologic intervention [2] . Effective management of UTI would usually require the use of antimicrobial agents. However, reports show increasing resistance among certain urinary pathogens (uropathogens) to some commonly used antimicrobial agents. A number of studies report resistance of uropathogens to some first line antibiotic therapy: 10 -20% for trimethoprim and sulfamethoxazole (TMP-SMX), 40% for ampicillin, 15 -20% for nitrofurantoin and less than 10% for the fluoroquinolones [2] [3] [4] [5] .
Among the various antimicrobials used in the treatment of UTIs, the fluoroquinolones remain the preferred class. This is due to the fact that fluoroquinolones have high bacteriologic and clinical cure rates, low resistance rates, and few adverse drug reactions [6, 7] .
Fluoroquinolones are bactericidal antibiotics that target specifically DNA gyrase of the microorganism. Amongst the most frequently prescribed fluoroquinolones for empirical treatment of UTIs are ciprofloxacin and levofloxacin [3, 8, 9] . Ciprofloxacin, a secondgeneration fluoroquinolone, has greater activity against Gramnegative bacteria compared to nalidixic acid (a first-generation quinolone). Levofloxacin, a third-generation fluoroquinolone, is known to have broad spectrum of activity against Gram-positive and Gram-negative bacteria, and atypical pathogens [10] . Despite the preference for fluoroquinolones in the management of UTIs, there are current reports that suggest emergence of uropathogen resistance to commonly prescribed fluoroquinolones [11, 12] . Data from Ghana and elsewhere show that isolated uropathogens have higher resistance to ciprofloxacin compared to levofloxacin [13] [14] [15] .
As a result of this, healthcare professionals in Ghana may sometimes prescribe levofloxacin instead of ciprofloxacin (which is first-line treatment)for uncomplicated UTI. Two recent studies at a secondary level quasi-government hospital in Ghana showed that isolated uropathogen exhibited 35.9 % resistance to ciprofloxacin [16] and 51.6% resistance to levofloxacin [17] . Data from the latter study showed that levofloxacin resistance among uropathogens was on the rise. Therefore, the current study sought to compare the susceptibility of uropathogens (clinical isolates) to levofloxacin and ciprofloxacin concurrently.
Methods
Study site: The study was conducted at a secondary level quasigovernment hospital, Ghana Police Hospital. The Hospital is a 100-bed facility providing healthcare to police personnel, their dependents, and the general public. The Out-patient Department of the Hospital provides service to over 100,000 patients each year.
Study design and population: This was a cross-sectional study that screened urine samples collected from suspected UTI patients Table 2 .
Discussion
Regular laboratory-based surveillance is important for local and national action in the monitoring of antimicrobial resistance (AMR) and its spread [19, 20] . Studies of such nature promote rational prescribing of antibiotics, and provide up-to-date information that direct policies aimed at addressing AMR. The current study showed that the prevalence of UTI was significantly (p < 0.05) higher in females (74.5%) compared to males (25.5%).This corroborates a study in Nigeria, where the prevalence of UTI was higher among females, 55.1%, than in males, 34.9% [21] . Other studies elsewhere have also showed that the prevalence of UTI in females is higher than in males [22, 23] . Factors such as hormonal changes during pregnancy, anatomical difference between the male and female urethra, proximity of the male and female urethra to anal opening, poor personal hygiene, some cultural practices among women and the absence of prostatic secretion in females could be underlying factors for the moderately high UTI prevalence observed among females than their male counterparts [23] . The age range with the highest infection, 49.7%, was in patient within 20-39 years.
Those with ages less than 20 years had the lowest infection (13.7%). The high rate of UTI among the age category 20-39 years could be due to the high incidence of sexual activity and/or multiple sex partners known to be associated with that age group [24] . UTI among patients within the age range of 40-59 (12.6%) and above 60 years (15%) observed in this study could be due to factors such as prostatic enlargement in males, reduced ambulation, catheterization, diabetes mellitus and weak bladder sphincters [25] . Reports from similar studies elsewhere revealed that, common pathogens in laboratory cultures of urine are Escherichia coli and Enterobacteriaceae [28, 29] . Previous studies conducted at the Ghana Police Hospital reported the presence of fungi, mixed fungi and bacteria, and mixed bacteria isolates [16, 17] . In the current study, bacteria were the pathogens isolated; Coliforms spp, Escherichia coli, Klebsiella spp and Staphylococcus aureus. The current study also showed that Escherichia coli and Coliform spp were the most prevalent uropathogens, accounting for 71.3%
of the clinical isolates. Similar studies in Ghana; Kumasi and Cape Coast Hospitals, however, reported Escherichia coli and Klebsiella spp as the most prevalent bacteria isolates responsible for UTI [30, 31] .
Although fluoroquinolones have been useful in the treatment of UTI, current reports in a number of countries, Ghana inclusive, suggest an increase in microbial resistance [13, 14, 32, 33] . A possible reason for this could be indiscriminate use of fluoroquinolones in the treatment of human and animal infections [34] . The current study revealed that, overall susceptibility of microbial organisms to levofloxacin was 62.8% and to ciprofloxacin was 77.1%. This observation suggests that, isolated uropathogens were more susceptible to ciprofloxacin than levofloxacin. On the contrary, findings from a similar study in a tertiary-care hospital in India reported uropathogen susceptibility of 46.2% for levofloxacin and 14.5% for ciprofloxacin [35] . Resistance of isolated uropathogens to
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respectively. The level of resistance to these two fluoroquinolones were higher than the 10% resistance observed in a similar study in United States of America [5] , but lower than findings from the study in India [35] . Further analysis of results also showed that, resistance of levofloxacin and ciprofloxacin to uropathogens in this study was lower than fluoroquinolone resistance (> 50%) reported after a recent nationwide antimicrobial resistance surveillance in Ghana [33] . Findings from this study (emerging resistance to fluoroquinolones) tend to agree with conclusions from a systematic review and meta-analysis of UTIs in West Africa from 1990 to 2012
by Bernabe et al [36] . Several studies have revealed that levofloxacin has better activity against Gram-positive bacteria, and less likely to select for resistant strains compared to the older quinolones [6, 37, 38] . However, the only Gram-positive isolate Staphylococcus aureus, identified in this study showed higher (75%) resistance to levofloxacin compared to ciprofloxacin (25%). 
Conclusion
In conclusion, this study showed that among uropathogens isolated at this quasi-government hospital, ciprofloxacin had greater activity 
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